Phase III efficacy and safety trial of a new leuprolide acetate 3.75 mg depot formulation in prostate cancer patients

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: 4365844c98fc63935af38eb1fb4c92b7fb7f088b
First added on: Mar 01, 2025